Patrick Flannery

479 total citations
20 papers, 229 citations indexed

About

Patrick Flannery is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Patrick Flannery has authored 20 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Pharmacology. Recurrent topics in Patrick Flannery's work include Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Glioma Diagnosis and Treatment (4 papers). Patrick Flannery is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (4 papers) and Glioma Diagnosis and Treatment (4 papers). Patrick Flannery collaborates with scholars based in United States, India and Saudi Arabia. Patrick Flannery's co-authors include Satyanarayana R. Pondugula, George Sakoulas, Sridhar Mani, Temesgen Samuel, Wen Xie, Elaine S. Coleman, John DeSisto, Rajeev Vibhakar, Muralikrishnan Dhanasekaran and Sujatha Venkataraman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Patrick Flannery

19 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick Flannery United States 9 88 49 42 42 30 20 229
Rhonda R. Holley-Shanks United States 6 67 0.8× 8 0.2× 98 2.3× 52 1.2× 11 0.4× 6 207
Mohammad Shadid United States 9 180 2.0× 7 0.1× 49 1.2× 18 0.4× 11 0.4× 13 349
Kevin M. Huang United States 12 103 1.2× 6 0.1× 151 3.6× 19 0.5× 12 0.4× 28 343
Munetoshi Sugiura Japan 11 158 1.8× 10 0.2× 62 1.5× 43 1.0× 5 0.2× 60 356
Leanne K. Winner Australia 8 88 1.0× 6 0.1× 78 1.9× 147 3.5× 24 0.8× 11 331
Hisanao Kishimoto Japan 14 85 1.0× 5 0.1× 103 2.5× 23 0.5× 5 0.2× 31 339
Yoshinobu Nakamaru Japan 10 92 1.0× 64 1.3× 56 1.3× 33 0.8× 23 0.8× 16 278
N. Kitrossky Israel 7 107 1.2× 9 0.2× 16 0.4× 12 0.3× 11 0.4× 9 359
Helena Gleissman Sweden 8 117 1.3× 54 1.1× 24 0.6× 3 0.1× 10 0.3× 11 363
Yoshio Kagitani Japan 10 84 1.0× 17 0.3× 21 0.5× 5 0.1× 5 0.2× 23 369

Countries citing papers authored by Patrick Flannery

Since Specialization
Citations

This map shows the geographic impact of Patrick Flannery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Flannery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Flannery more than expected).

Fields of papers citing papers by Patrick Flannery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Flannery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Flannery. The network helps show where Patrick Flannery may publish in the future.

Co-authorship network of co-authors of Patrick Flannery

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Flannery. A scholar is included among the top collaborators of Patrick Flannery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Flannery. Patrick Flannery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Knox, Aaron J., Benjamin Van Court, Ayman Oweida, et al.. (2023). A novel preclinical model of craniospinal irradiation in pediatric diffuse midline glioma demonstrates decreased metastatic disease. Frontiers in Oncology. 13. 1105395–1105395. 3 indexed citations
2.
Flannery, Patrick, Aneesh Chandran, Saraswathi Vishveshwara, et al.. (2022). Gefitinib Inhibits Rifampicin-Induced CYP3A4 Gene Expression in Human Hepatocytes. ACS Omega. 7(38). 34034–34044.
3.
Flannery, Patrick, et al.. (2022). Interplay between the Cannabinoid System and microRNAs in Cancer. ACS Omega. 7(12). 9995–10000. 4 indexed citations
4.
Flannery, Patrick, et al.. (2021). Acute Psychosis Due to Anti-N-Methyl D-Aspartate Receptor Encephalitis Following COVID-19 Vaccination: A Case Report. Frontiers in Neurology. 12. 764197–764197. 35 indexed citations
5.
Pondugula, Satyanarayana R., Patrick Flannery, Mohammed Majrashi, et al.. (2021). A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J mice. Liver Research. 5(4). 239–242. 10 indexed citations
6.
Pondugula, Satyanarayana R., Patrick Flannery, Mohammed Majrashi, et al.. (2021). Oroxylum indicum Extract, at a Physiologically Relevant Dosage, Does Not Induce Hepatotoxicity in C57BL/6J Mice. Natural Product Communications. 16(5). 4 indexed citations
7.
Flannery, Patrick, et al.. (2020). Nothing Ventured, Nothing Gained: Regulations Cripple Potentially Life-Saving Research of Illicit Substances. ACS Chemical Neuroscience. 11(10). 1382–1384. 3 indexed citations
8.
Flannery, Patrick, et al.. (2020). Dysregulation of Endobiotic Homeostasis Mechanisms: Novel Insights into Adverse Pharmacokinetic Interactions between Illicit Substances and Clinical Drugs. ACS Chemical Neuroscience. 11(24). 4021–4023. 1 indexed citations
9.
Flannery, Patrick, et al.. (2020). Crazy-Paving: A Computed Tomographic Finding of Coronavirus Disease 2019. SHILAP Revista de lepidopterología. 4(3). 461–463. 2 indexed citations
10.
DeSisto, John, Patrick Flannery, Amrita Pathak, et al.. (2019). Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma. Molecular Cancer Therapeutics. 19(2). 540–551. 18 indexed citations
11.
Flannery, Patrick, et al.. (2019). Adverse pharmacokinetic interactions between illicit substances and clinical drugs. Drug Metabolism Reviews. 52(1). 44–65. 19 indexed citations
12.
Flannery, Patrick, et al.. (2019). Correlation of PPM1A Downregulation with CYP3A4 Repression in the Tumor Liver Tissue of Hepatocellular Carcinoma Patients. European Journal of Drug Metabolism and Pharmacokinetics. 45(2). 297–304. 11 indexed citations
13.
Lucas, John T., John DeSisto, Gang Wu, et al.. (2018). Comprehensive molecular characterization of pediatric treatment-induced glioblastoma: Germline DNA repair defects as a potential etiology.. Journal of Clinical Oncology. 36(15_suppl). 10573–10573. 1 indexed citations
14.
DeSisto, John, Patrick Flannery, Trinayan Kashyap, et al.. (2017). Abstract 1946: Synergistic effects of the XPO1 inhibitor selinexor with proteasome inhibitors in pediatric high-grade glioma and diffuse intrinsic pontine glioma. Cancer Research. 77(13_Supplement). 1946–1946. 1 indexed citations
15.
Flannery, Patrick, John DeSisto, Vladimir Amani, et al.. (2017). Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma. Oncology Reports. 39(2). 455–464. 26 indexed citations
16.
DeSisto, John, et al.. (2017). HGG-17. PEDIATRIC RADIATION-INDUCED GLIOBLASTOMA: TRANSCRIPTOMIC AND DRUG SCREENING ANALYSIS OF PRIMARY PATIENT SAMPLES. Neuro-Oncology. 19(suppl_4). iv26–iv26. 2 indexed citations
17.
Karthikeyan, Chandrabose, Charles R. Ashby, Haneen Amawi, et al.. (2016). Pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinolines: Novel compounds that reverse ABCG2-mediated resistance in cancer cells. Cancer Letters. 376(1). 118–126. 28 indexed citations
18.
Pondugula, Satyanarayana R., Patrick Flannery, Udayan Apte, et al.. (2015). Mg2+/Mn2+-Dependent Phosphatase 1A Is Involved in Regulating Pregnane X Receptor–Mediated Cytochrome p450 3A4 Gene Expression. Drug Metabolism and Disposition. 43(3). 385–391. 16 indexed citations
19.
Pondugula, Satyanarayana R., et al.. (2014). Plant-based omega-3 stearidonic acid enhances antitumor activity of doxorubicin in human prostate cancer cell lines. 2(9). 132–143. 5 indexed citations
20.
Pondugula, Satyanarayana R., Patrick Flannery, Elaine S. Coleman, et al.. (2014). Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR. Toxicology Letters. 232(3). 580–589. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rhonda R. Holley-Shanks Breakdown of academic impact, for papers by Mohammad Shadid Breakdown of academic impact, for papers by Kevin M. Huang Breakdown of academic impact, for papers by Munetoshi Sugiura Breakdown of academic impact, for papers by Leanne K. Winner Breakdown of academic impact, for papers by Hisanao Kishimoto Breakdown of academic impact, for papers by Yoshinobu Nakamaru Breakdown of academic impact, for papers by N. Kitrossky Breakdown of academic impact, for papers by Helena Gleissman Breakdown of academic impact, for papers by Yoshio Kagitani
Rankless by CCL
2026